Ann Nutr Metab 48(3): 169-188
We believe these data underscore the potential of CagriSema to address unmet medical needs in obesity and support long-term disease management." The NDA is based on results from REDEFINE 1, a 68-week, phase 3, randomized, double-blind, placebo-and active-controlled trial that evaluated the efficacy and safety of once-weekly CagriSema compared to semaglutide 2.4 mg alone, cagrilintide 2.4 mg alone, or placebo, all as an adjunct to lifestyle intervention in 3,417 adults with obesity (BMI 30 kg/m 2 ) or overweight (BMI 27 kg/m 2 ) with one or more obesity-related complications and without diabetes, and REDEFINE 2, a double-blind, randomized, placebo-controlled, 68-week, phase 3 trial that evaluated the efficacy and safety of once-weekly CagriSema versus placebo, as an adjunct to lifestyle intervention in 1,206 adults with type 2 diabetes and either obesity (BMI 30 kg/m 2 ) or overweight (BMI 27 kg/m 2 )
A large portion of cytoplasmic iron is contained in the lysosome (Yu et al., 2003)
Retatrutide (triple agonist) If tirzepatide was a step forward, retatrutide is a leap
What to exclude entirely: retinoids (at least during active flares), alpha-hydroxy acids, benzoyl peroxide, physical scrubs, and any product with fragrance or alcohol listed in its first five ingredients
This helps support the free content for the community on this website